Edge Wealth Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Edge Wealth Management’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,000	Closed	-$5K	–	501
2021 Q4	$5K	Hold	1,000	–	–	﹤0.01%	338
2021 Q3	$6K	Hold	1,000	–	–	﹤0.01%	339
2021 Q2	$7K	Hold	1,000	–	–	﹤0.01%	332
2021 Q1	$7K	Hold	1,000	–	–	﹤0.01%	321
2020 Q4	$6K	Hold	1,000	–	–	﹤0.01%	296
2020 Q3	$6K	Hold	1,000	–	–	﹤0.01%	354
2020 Q2	$5K	Hold	1,000	–	–	﹤0.01%	566
2020 Q1	$4K	Hold	1,000	–	–	﹤0.01%	510
2019 Q4	$6K	Hold	1,000	–	–	﹤0.01%	481
2019 Q3	$8K	Hold	1,000	–	–	﹤0.01%	441
2019 Q2	$7K	Hold	1,000	–	–	﹤0.01%	462
2019 Q1	$8K	Hold	1,000	–	–	﹤0.01%	435
2018 Q4	$16K	Hold	1,000	–	–	﹤0.01%	356
2018 Q3	$33K	Hold	1,000	–	–	0.01%	307
2018 Q2	$23K	Hold	1,000	–	–	0.01%	342
2018 Q1	$29K	Hold	1,000	–	–	0.01%	271
2017 Q4	$28K	Hold	1,000	–	–	0.01%	282
2017 Q3	$36K	Hold	1,000	–	–	0.01%	249
2017 Q2	$22K	Hold	1,000	–	–	0.01%	296
2017 Q1	$6K	Hold	1,000	–	–	﹤0.01%	407
2016 Q4	$5K	Hold	1,000	–	–	﹤0.01%	397
2016 Q3	$9K	Hold	1,000	–	–	﹤0.01%	349
2016 Q2	$10K	Hold	1,000	–	–	﹤0.01%	318
2016 Q1	$9K	Hold	1,000	–	–	﹤0.01%	300
2015 Q4	$13K	Hold	1,000	–	–	﹤0.01%	273
2015 Q3	$12K	Hold	1,000	–	–	﹤0.01%	278
2015 Q2	$18K	Hold	1,000	–	–	0.01%	254
2015 Q1	$14K	Hold	1,000	–	–	﹤0.01%	283
2014 Q4	$8K	Hold	1,000	–	–	﹤0.01%	319
2014 Q3	$11K	Hold	1,000	–	–	﹤0.01%	305
2014 Q2	$18K	Hold	1,000	–	–	0.01%	259
2014 Q1	$15K	Hold	1,000	–	–	0.01%	263
2013 Q4	$18K	Sell	1,000 -70	-7%	-$1.4K	0.01%	232
2013 Q3	$22K	Hold	1,070	–	–	0.01%	194
2013 Q2	$27K	Buy	+1,070	New	+$45.7K	0.02%	167

Other funds holding AVEO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Edge Wealth Management's AVEO Position: Q1 2022 in Review

Edge Wealth Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2022, closing a stake of 1,000 shares — an estimated $5K sold.

Edge Wealth Management first reported a position in AVEO in Q2 2013 and held it in 35 quarters. The position peaked at $36K in Q3 2017. 58 funds tracked by Wall St. Rank hold AVEO as of Q1 2022.

Edge Wealth Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2022 after selling out during the quarter.
Edge Wealth Management sold 1,000 AVEO Pharmaceuticals, Inc. shares in Q1 2022, an estimated $5K.
Edge Wealth Management first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 35 quarters.
Edge Wealth Management's AVEO Pharmaceuticals, Inc. position peaked at $36K in Q3 2017.
58 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2022.

Based on Edge Wealth Management's 13F filing for Q1 2022, filed 14 Apr 2022.